Earnings calls

Zydus Wellness concall ledger

Every earnings call for ZYDUSWELL — management tone, guidance, KPIs and promise tracking, quarter by quarter.

ZYDUSWELL · 5 transcripts · Fast Moving Consumer Goods · latest Q4 FY26

Q4 FY26Published 18 May 2026Call held 18 May 2026

ZYDUSWELL Q4 FY26 Earnings Call Transcript & Analysis

EBITDA₹270.1 cr+42% YoY

EBITDA (Q4) ₹270 cr (+42% YoY). Net sales grew 62.1% in Q4 FY26 and 46.4% for the full year FY26.

Read full transcript & analysis

Q3 FY26Published 03 Feb 2026Call held 03 Feb 2026

ZYDUSWELL Q3 FY26 Earnings Call Transcript & Analysis

Consolidated EBITDA610 million+312% YoYEBITDA Margin6.3%Gross Margin63%

Consolidated EBITDA 610 million (+312% YoY); EBITDA Margin 6.3%; Gross Margin 63%. Net sales grew 113.7% YoY to INR610 million EBITDA.

Read full transcript & analysis

Q2 FY26Published 05 Nov 2025Call held 05 Nov 2025

ZYDUSWELL Q2 FY26 Earnings Call Transcript & Analysis

Consolidated EBITDA₹23 cr+17% YoY

Consolidated EBITDA (Q2) ₹23 cr (+17% YoY). Consolidated net sales grew 31% for the quarter and 12.8% for H1 FY26.

Read full transcript & analysis

Q1 FY26Published 30 Jul 2025Call held 30 Jul 2025

ZYDUSWELL Q1 FY26 Earnings Call Transcript & Analysis

Consolidated Net Sales8,577 million+2% YoYEBITDA1,556 millionPAT—−13% YoY

Consolidated Net Sales 8577 million (+2% YoY); EBITDA 1556 million (+0% YoY). Consolidated net sales grew 2.2% to ₹8,577 million.

Read full transcript & analysis

Q4 FY25Published 23 May 2025Call held 23 May 2025

ZYDUSWELL Q4 FY25 Earnings Call Transcript & Analysis

Revenue₹910.6 cr+17% YoYEBITDA₹190 cr+17% YoYEPS₹54.52+30% YoY

Revenue (Q4) ₹911 cr (+17% YoY); EBITDA (Q4) ₹190 cr (+17% YoY); EPS (FY25) ₹54.52 (+30% YoY). Consolidated net sales grew 17% in Q4 FY25 to ₹910.6 crores and 16.2% for FY25 to ₹2691.2 crores.

Read full transcript & analysis